| scholarly article | Q13442814 |
| P2093 | author name string | Eduard J Beck | |
| Peter Ghys | |||
| Olufunke Fasawe | |||
| Paul De Lay | |||
| Carlos Avilla | |||
| Patricia Ongpin | |||
| P2860 | cites work | Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 |
| HIV prevention programmes for female sex workers in Andhra Pradesh, India: outputs, cost and efficiency | Q24816879 | ||
| Inflammatory and coagulation biomarkers and mortality in patients with HIV infection | Q28473903 | ||
| Cost-Effectiveness of Pooled Nucleic Acid Amplification Testing for Acute HIV Infection after Third-Generation HIV Antibody Screening and Rapid Testing in the United States: A Comparison of Three Public Health Settings | Q28475627 | ||
| Association of low level viremia with inflammation and mortality in HIV-infected adults | Q28743237 | ||
| Rising population cost for treating people living with HIV in the UK, 1997-2013 | Q28743848 | ||
| Why and how to monitor the cost and evaluate the cost-effectiveness of HIV services in countries. | Q30371041 | ||
| Counting the cost of not costing HIV health facilities accurately: pay now, or pay more later | Q30419644 | ||
| Modelling the impact and cost-effectiveness of the HIV intervention programme amongst commercial sex workers in Ahmedabad, Gujarat, India | Q30480165 | ||
| Outputs and cost of HIV prevention programmes for truck drivers in Andhra Pradesh, India | Q33449065 | ||
| Determining a cost effective intervention response to HIV/AIDS in Peru | Q33504903 | ||
| The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women | Q33559823 | ||
| Costs and outcomes of VCT delivery models in the context of scaling up services in Indonesia | Q33744330 | ||
| Estimating the cost of care giving on caregivers for people living with HIV and AIDS in Botswana: a cross-sectional study | Q33891317 | ||
| The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda | Q34029513 | ||
| Voluntary medical male circumcision: a qualitative study exploring the challenges of costing demand creation in eastern and southern Africa | Q34090990 | ||
| Comparing antiretroviral treatment outcomes between a prospective community-based and hospital-based cohort of HIV patients in rural Uganda | Q34100042 | ||
| Cost of community integrated prevention campaign for malaria, HIV, and diarrhea in rural Kenya | Q34107939 | ||
| HIV Infection, Inflammation, Immunosenescence, and Aging | Q34150710 | ||
| The costs of HIV prevention for different target populations in Mumbai, Thane and Bangalore | Q34178473 | ||
| The cost of HIV treatment and care. A global review | Q34185255 | ||
| Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort | Q34204026 | ||
| Cost of using a patient tracer to reduce loss to follow-up and ascertain patient status in a large antiretroviral therapy program in Johannesburg, South Africa | Q34687558 | ||
| The costs and effectiveness of four HIV counseling and testing strategies in Uganda | Q34912202 | ||
| CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study | Q35541572 | ||
| Increasing access to HIV counseling and testing through mobile services in Kenya: strategies, utilization, and cost-effectiveness | Q35576230 | ||
| The effects of scale on the costs of targeted HIV prevention interventions among female and male sex workers, men who have sex with men and transgenders in India | Q35656683 | ||
| Case management to improve adherence for HIV-infected patients receiving antiretroviral therapy in Ethiopia: a micro-costing study | Q35690109 | ||
| Cost effectiveness of facility-based care, home-based care and mobile clinics for provision of antiretroviral therapy in Uganda | Q35834613 | ||
| Preventing HIV in injection drug users: choosing the best mix of interventions for the population | Q36272465 | ||
| Integrating tuberculosis and HIV services for people living with HIV: costs of the Zambian ProTEST Initiative. | Q36493894 | ||
| From the asylum to community care: learning from experience | Q36716098 | ||
| Changing cost of HIV interventions in the context of scaling-up in India | Q36944602 | ||
| Costs of measures to control tuberculosis/HIV in public primary care facilities in Cape Town, South Africa | Q37063602 | ||
| Early immune senescence in HIV disease | Q37084912 | ||
| The costs of a sexually transmitted infection outreach and treatment programme targeting most at risk youth in Tajikistan | Q37428151 | ||
| Feasibility, acceptability and cost of home-based HIV testing in rural Kenya | Q37529898 | ||
| The cost of treatment and care for people living with HIV infection: implications of published studies, 1999-2008. | Q37764264 | ||
| Peer referral for HIV case-finding among men who have sex with men. | Q37861409 | ||
| The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review | Q38064243 | ||
| A pilot project for the effective delivery of HAART in rural China | Q38453852 | ||
| Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda | Q38869763 | ||
| The role of community acceptance over time for costs of HIV and STI prevention interventions: analysis of the Masaka Intervention Trial, Uganda, 1996-1999. | Q38879801 | ||
| Clinical care as part of integrated AIDS management in a Zambian rural community | Q38941084 | ||
| Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania | Q39024161 | ||
| Prioritization of prevention activities to combat the spread of HIV/AIDS in resource constrained settings: a cost-effectiveness analysis from Chad, Central Africa | Q39090148 | ||
| The cost of home-based care for HIV/AIDS patients in Zimbabwe | Q39485253 | ||
| Demograghic and socio-economic determinants of community and hospital services costs for people with HIV/AIDS in London. | Q39510516 | ||
| Are targeted HIV prevention activities cost-effective in high prevalence settings? Results from a sexually transmitted infection treatment project for sex workers in Johannesburg, South Africa | Q39559497 | ||
| Cost-effectiveness of a community-level HIV risk reduction intervention for women living in low-income housing developments | Q39722388 | ||
| The costs of HIV antiretroviral therapy adherence programs and impact on health care utilization | Q39833472 | ||
| The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa | Q39853498 | ||
| Cost-effectiveness of environmental-structural communication interventions for HIV prevention in the female sex industry in the Dominican Republic | Q40263150 | ||
| Scaling-up HIV/AIDS and TB home-based care: lessons from Zambia | Q40689098 | ||
| Evaluation of the transprofessional model of home health care for HIV/AIDS. | Q41666939 | ||
| Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre | Q42623149 | ||
| Cost of OraQuick oral fluid rapid HIV testing at 35 community clinics and community-based organizations in the USA. | Q43898548 | ||
| Towards an improved investment approach for an effective response to HIV/AIDS. | Q44667685 | ||
| Comparing the cost-effectiveness of HIV prevention interventions | Q45106338 | ||
| The cost effectiveness of integrated care for people living with HIV including antiretroviral treatment in a primary health care centre in Bujumbura, Burundi | Q45238075 | ||
| Cost effectiveness analysis of the New Jersey rapid testing algorithm for HIV testing in publicly funded testing sites | Q45400734 | ||
| Costs and effectiveness of finding new HIV diagnoses by using rapid testing in transgender communities | Q46074705 | ||
| Providing universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS care | Q46346006 | ||
| Condom distribution: a cost-utility analysis | Q46462738 | ||
| An assessment of cost, quality and outcomes for five HIV prevention youth peer education programs in Zambia | Q46979031 | ||
| Prevention of HIV infection in drug abusers: a cost analysis | Q49211461 | ||
| Improving the cost-effectiveness of AIDS health care in San Juan, Puerto Rico | Q50545016 | ||
| Do peer educators make a difference? An evaluation of a youth-led HIV prevention model in Zambian Schools. | Q51171039 | ||
| Cost-effectiveness of a community-level HIV risk reduction intervention. | Q52237911 | ||
| Cost-effectiveness analysis of recruitment strategies in a community-based intervention study of HIV-infected persons | Q58306670 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 293-311 | |
| P577 | publication date | 2013-06-01 | |
| P1433 | published in | Expert Review of Pharmacoeconomics & Outcomes Research | Q15734522 |
| P1476 | title | Costs and cost-effectiveness of HIV community services: quantity and quality of studies published 1986-2011. | |
| P478 | volume | 13 |
Search more.